Carbiotix AB (CRBX.ST) Research

Carbiotix AB is a therapeutics company currently in the pre-clinical development stage. It specializes in creating products and medicines intended to stimulate beneficial bacteria in the gut, with the aim of addressing metabolic and chronic illnesses. The company was established in 2014 and is headquartered in Lund, Sweden.

Market snapshot

Symbol
CRBX.ST
Price
$6.58
Day change
+14.24%
Market cap
$32.7M
P/E ratio
-2.25x
52-week range
3.7-14.75
Sector
Industrials
Industry
Specialty Business Services

Peer companies

  • CirChem AB (publ) (CIRCHE.ST)
  • Hedera Group AB (publ) (HEGR.ST)
  • Heliospectra AB (publ) (HELIO.ST)
  • Hexicon AB (publ) (HEXI.ST)
  • Irisity AB (publ) (IRIS.ST)
  • Mantex AB (publ) (MANTEX.ST)
  • MoveByBike Europe AB (publ) (MBBAB.ST)
  • Nordic Flanges Group AB (publ) (NFGAB.ST)

Open Carbiotix AB (CRBX.ST) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.